SCHEMBL32669271

SCHEMBL32669271

CCN(CC)CCc1c[nH]c2ncccc12

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 4/20 0.60
HTR6 P50406 2/20 0.60
GPR84 Q9NQS5 1/20 0.59
MTNR1A P48039 1/20 0.56
RET P07949 1/20 0.53
MET P08581 1/20 0.52
HTR2A P28223 1/20 0.52
BCHE P06276 1/20 0.49
HTR1D P28221 2/20 0.48
MPO P05164 1/20 0.48
CCNE1 P24864 3/20 0.46
CDK2 P24941 3/20 0.46
FGFR1 P11362 1/20 0.46
FGFR4 P22455 1/20 0.46
HTR7 P34969 1/20 0.46
AXL P30530 1/20 0.45
DRD2 P14416 1/20 0.45
DRD4 P21917 1/20 0.45
DRD3 P35462 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25029946 0.88 GPR84 (0.59) HTR1AHTR6GPR84MTNR1AMET
SCHEMBL6359455 0.85 GPR84 (0.63) HTR1AHTR6GPR84MTNR1ARET
SCHEMBL30886870 0.85 GPR84 (0.63) HTR1AHTR6GPR84MTNR1ARET
Hydrochloric Acid SCHEMBL4869205 0.84 GPR84 (0.61) HTR1AHTR6GPR84MTNR1ARET
SCHEMBL857145 0.83 GPR84 (0.69) HTR6GPR84MTNR1AMETHTR2A
SCHEMBL878813 0.81 GPR84 (0.51) HTR1AHTR6GPR84MTNR1ARET
SCHEMBL21143167 0.80 GPR84 (0.65) HTR6GPR84MTNR1AMETBCHE
SCHEMBL25030247 0.80 GPR84 (0.56) HTR1AGPR84MTNR1AMETHTR2A
SCHEMBL32669457 0.80 GPR84 (0.69) GPR84MTNR1AMETCCNE1CDK2
SCHEMBL2692513 0.79 GPR84 (0.73) HTR6GPR84MTNR1ARETMET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260034119-A1 5-METHOXY-N,N-DIMETHYLTRYPTAMINE ANALOGS, THEIR SYNTHESIS, AND METHODS FOR TREATMENT OF NEUROLOGICAL, PSYCHIATRIC, AND SUBSTANCE USE DISORDERS THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2026-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260034119-A1 5-METHOXY-N,N-DIMETHYLTRYPTAMINE ANALOGS, THEIR SYNTHESIS, AND METHODS FOR TREATMENT OF NEUROLOGICAL, PSYCHIATRIC, AND SUBSTANCE USE DISORDERS HTR4, OPRM1, HTR7 HTR1A 4/4885HTR6 8/4885GPR84 391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.